A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for the Study of Diabetes (EASD) meetings. This is an EASD/American Diabetes ...

Welcome, everyone, to the BioStock Studio where we today are doing this live webcast. Thank you for tuning in. So we are meeting today in the context of the World Diabetes Day. It's a day to raise ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system ...